Skip to main content
Innovotech Inc. logo

Innovotech Inc. — Investor Relations & Filings

Ticker · IOT ISIN · CA45772U1049 TSXV Professional, scientific and technical activities
Filings indexed 330 across all filing types
Latest filing 2020-05-28 Interim / Quarterly Rep…
Country CA Canada
Listing TSXV IOT

About Innovotech Inc.

https://innovotech.ca/

Innovotech Inc. is a specialist in antimicrobial and biofilm solutions, recognized as a pioneer in biofilm product development and contract research. The company focuses on providing innovative and practical solutions to medical, agricultural, and industrial problems caused by microbial biofilms. Key offerings include specialized assay kits used globally for growing microbial biofilms in research applications. Through Innovotech Labs, the company provides comprehensive, accredited (GMP and ISO) contract testing services, including analytical, microbiological, and antimicrobial testing. These services target the pharmaceutical, biotechnology, medical device, and nutraceutical industries, aiming to ensure regulatory compliance and product optimization.

Recent filings

Filing Released Lang Actions
Interim financial statements/report – English.pdf
Interim / Quarterly Report Classification · 100% confidence The document is titled 'Interim Financial Statements (Unaudited) For the three-month period ended March 31, 2020 and 2019' and contains detailed financial statements including Statements of Financial Position, Statements of Operations and Comprehensive Income (Loss), Statements of Cash Flows, and Notes to Financial Statements. It explicitly states it is unaudited interim financial statements for a quarter (three-month period). The presence of substantive financial data and analysis for a period shorter than a full fiscal year confirms this is an Interim / Quarterly Report. There is no indication that this is merely an announcement or a certification, and the document length is substantial (11,947 characters), supporting it being a full report rather than a brief notice or announcement. Q1 2020
2020-05-28 English
News release - English.pdf
Regulatory Filings
2020-05-28 English
Audited annual financial statements (amended) - English.pdf
Regulatory Filings
2020-04-30 English
News release - English.pdf
Regulatory Filings
2020-04-29 English
52-109FV1 - Certification of annual filings - CEO (E).pdf
Regulatory Filings
2020-04-29 English
Annual MD&A - English.pdf
Regulatory Filings
2020-04-29 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.